GSK plc increased the Book Value of net Assets by £1,221 million, from £15,956 million at 31 December 2025 to £17,177 million at 30 June 2026. The update gives investors a £563 million pension surplus and transition adjustments affecting trade and other payables and cash.

Key Highlights

  • GSK’s pension plans showed a £563 million net surplus at 30 June.
  • Core results exclude major restructuring programmes involving projects exceeding £25 million.
  • Net assets increased by £1,221 million, from £15,956 million at 31 December 2025 to £17,177 million at 30 June 2026.
  • Pension plans held a net surplus of £563 million at 30 June, compared with £229 million at 31 December 2025.

GSK plc (NYSE: GSK) increased the book value of net assets by £1,221 million, taking the balance from £15,956 million at 31 December 2025 to £17,177 million at 30 June 2026.

Balance Sheet Adjustments at 30 June

GSK’s pension plans held a net surplus of £563 million at 30 June, compared with £229 million at 31 December 2025. The reporting framework identifies major restructuring programmes through projects exceeding £25 million, while certain Subsidiary Liquidation items are also excluded when they exceed £25 million.

Pension Surplus and Rate Changes

The pension surplus movement was primarily driven by the UK discount rate rising from 5.5% to 6.0%. The comparison with the £229 million surplus at 31 December 2025 gives investors a separate measure of the pension position alongside the reported net-asset balance. GSK’s core results exclude selected amortisation, impairment, restructuring, transaction and legal items, while Total results include them.